fastbuck all my reading is indicating MEIP own it as it was part...

fastbuck  all my reading is indicating MEIP own it as it was part of the IP as Novogen mk 1 was left a shell with about a million in cash and a dual listing?
Maybe there are timelines if a drug company doesn't do something with it then another company is allowed to?

That whole past thing is way to busy around 2012 and I think so as not to get lost we're probably better informed to read the market releases:

From GK in chairman's address in 30 June 2013 annual report:

"....When the current Board assumed control of the Novogen on 5 December 2012, Novogen was a shell. All of its drug technology intellectual property had been sold to subsidiary, MEI Pharma..."

http://hotcopper.com.au/threads/ann-annual-report-to-shareholders.2092808/#.V7eYIZh9670

I have read this enough to be fairly confident in saying MEIP owned all the IP which by extension would have included Phenodoxial